PROMEDIUS

What PROMEDIUS does

PROMEDIUS pioneers advanced AI breakthroughs in age-related conditions, including osteoporosis. The company's mission is to redefine aging as a new possibility for healthy aging through its AI technology. They develop AI software for medical image analysis, specifically focusing on chest X-ray based osteoporosis diagnosis support and abdominal CT-based muscle/fat segmentation.

Products

• Osteo SignalThe world's first screening solution that utilizes chest X-ray images to identify patients who may be at risk of osteoporosis. It provides osteoporosis diagnosis support AI software for clinicians and bone health care guides for patients. It has proven accuracy with an AUC of 0.91 for osteoporosis screening.
• Myo SignalAbdominal CT-based muscle/fat segmentation AI software that segments and quantifies fat and muscle quality by leveraging abdominal CT images. It automatically extracts the L3 slice, segments and measures muscle/fat area, and provides rich information in diverse reports including key indicators associated with metabolic diseases.

Key capabilities

• Chest X-ray based osteoporosis diagnosis support AI software
• Abdominal CT-based muscle/fat segmentation AI software
• AI-powered opportunistic osteoporosis screening
• Automated L3 slice extraction from abdominal CT images
• Segmentation and measurement of muscle/fat area
• Detailed reports for clinicians and patients
• Integration with existing PACS systems
• High accuracy in osteoporosis screening (AUC 0.91 for Osteo Signal)
• High muscle/fat segmentation alignment (96% for Myo Signal)
• Provides indices like Visceral Fat Area (VFA), Normal Attenuation Muscle Area (NAMA), Low Attenuation Muscle Area (LAMA)
• Comparison to averages and distributions of healthy adults and age-matched populations

Use cases

• Early identification of patients at risk of osteoporosis
• Diagnosis support for osteoporosis using chest X-rays
• Assessment of muscle and fat quality from abdominal CT images
• Screening for metabolic diseases (e.g., Type 2 diabetes mellitus, NAFLD, Sarcopenia, Myosteatosis)
• Providing bone health care guidance to patients
• Supporting clinicians in recommending further bone density examinations

AI approach

PROMEDIUS develops AI software for medical image analysis, specifically for age-related conditions. Their products, Osteo Signal and Myo Signal, use deep learning algorithms trained on large datasets of medical images (chest X-rays and abdominal CT scans) to identify risks of osteoporosis and analyze muscle/fat distribution, respectively. They claim high accuracy for their models.

Tech named: AI, Deep Learning

Industries served

• Medical Equipment Manufacturing
• Healthcare

What it says sets it apart

• World's first chest X-ray based osteoporosis screening solution
• Proprietary AI technology for age-related conditions
• High accuracy and proven performance in clinical studies
• Focus on healthy aging through AI
• Seamless integration with existing medical imaging systems (PACS)
• Comprehensive reports for both clinicians and patients

Funding rounds we track

From the AI funding tracker — rounds as reported by the linked publications.